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Cells expressing the spike (S) glycoprotein of the neurotropic JHM strain (JHMV) of mouse hepatitis virus (MHV) are
susceptible to lysis by B cells derived from naı¨ve mice, including B cells from perforin-deficient mice. Cytolysis requires
interaction of the virus receptor and the viral S glycoprotein, is independent of other viral-induced components, and is not
a unique property of B cells. Neutralizing anti-S-protein monoclonal antibodies (mAb) and a mAb specific for the viral receptor
inhibit lysis. However, cells infected with an MHV strain unable to induce cell–cell fusion are resistant to lysis and lysis of
JHMV-infected cells is inhibited by an anti-S-protein nonneutralizing mAb which prevents S-protein-mediated cell fusion.
These data suggest that B cells may function as antibody-independent innate immune response during JHMV infection in vivo.
© 2001 Academic Press
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Cellular components of the immune system, including
natural killer (NK) cells, B cells, macrophages, and both
CD41 and CD81 T cells, are recruited into the central
ervous system (CNS) following infection with the neu-
otropic JHM strain of mouse hepatitis virus (JHMV)
Bergmann et al., 1999; Dorries et al., 1991; Williamson,
992; Williamson et al., 1991). Mice deficient in either
D41 or CD81 T cells exhibit enhanced mortality follow-
ing infection (Williamson and Stohlman, 1990), suggest-
ing T cells are the predominant antiviral immune effec-
tors. However, CD41 T cells appear to play a secondary
role in viral clearance by enhancing CD81 T cell survival
or function (Stohlman et al., 1998). Therefore, similar to
many other viral infections (Kagi et al., 1995), most inter-
est has focused on CD81 T cells as the major effectors
of JHMV clearance (Stohlman et al., 1999). NK cells were
suggested to exhibit limited antiviral activity based on
the observation that JHMV replication within the CNS of
mice deficient in either CD41 or CD81 T cells is partially
nhibited (Williamson and Stohlman, 1990). However,
here is little evidence for a direct role of NK cells in
educing infectious virus (Houtman and Fleming, 1996)
nd, in contrast to T cells, NK cells are not retained in the
NS following viral clearance (Marten et al., 2001).
Humoral immunity has also been implicated in JHMV
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160nfection of the CNS. B cells are rapidly recruited into the
NS during acute JHMV infection (Dorries et al., 1991;
illiamson et al., 1991; Williamson, 1992) and antiviral
ntibody (Ab) is present in the cerebral spinal fluid during
oth acute infection and viral persistence (Dorries et al.,
986, 1987; Fleming et al., 1983a). Suckling mice weaned
n immunized dams are protected from acute encepha-
itis (Perlman et al., 1987) and JHMV-resistant Brown
orway rats develop a more rapid neutralizing Ab re-
ponse compared to susceptible Lewis rats (Dorries et
l., 1986, 1987), also supporting a role for humoral im-
unity. Passive transfer of neutralizing anti-spike (S) pro-
ein monoclonal antibody (mAb) protects mice from lethal
hallenge, although not all mAb with neutralizing activity
xhibit this in vivo activity (Buchmeier et al., 1984). In
ddition, mAb specific for other viral structural proteins,
hich lack neutralizing activity, also protect mice from
ouse hepatitis virus (MHV) infection (Fleming et al.,
989; Lecomte et al., 1987; Nakanaga et al., 1986;
okomori et al., 1992). However, the inability to detect
HMV-neutralizing Ab prior to clearance of the majority of
nfectious virus from the CNS suggested that humoral
mmunity played little or no role in initial JHMV clearance
Parra et al., 1997, 1999; Stohlman et al., 1986, 1999).
nfection of mice lacking the ability to produce Ab by
irtue of the absence of mature B cells (mMT mice)
demonstrated that infectious virus is initially cleared
from the CNS with kinetics similar to that of wild-type (wt)
mice (Lin et al., 1999). These data indicated that the
antiviral cellular immune response inhibits infectious vi-
rus replication in the absence of humoral immunity. How-
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161B CELL LYSIS OF MHV-INFECTED CELLSever, in contrast to wt mice, in which infectious virus is
completely cleared from the CNS by approximately 2
weeks postinfection (p.i.), low levels of residual virus
remained in the CNS of mMT mice.
Following initial, but incomplete, clearance, virus rep-
lication rapidly increased within the CNS of mMT mice
(Lin et al., 1999). Viral reactivation within the CNS of mMT
ice is prevented by the passive transfer of polyclonal
ntiviral Ab, but not nonspecific Ab (Lin et al., 1999),
uggesting that humoral immunity is critical for maintain-
ng viral persistence. However, the mechanism(s) which
ontributes to the prevention of JHMV reactivation within
he CNS of wt mice is not clear. The absence of both B
ells and Ab in mMT mice leaves open the question of
hether B cells play an Ab-independent role in either
uppressing virus replication during acute infection or
imiting subsequent CNS virus reactivation. A potential
b-independent role of B cells would be masked by the
eutralization of infectious virus via passive transfer of
olyclonal Ab (Lin et al., 1999). Although Ab appears to
e a critical component in establishing and/or maintain-
ng CNS viral persistence (Lin et al., 1999), the rapid
nflux of B cells into the CNS (Dorries et al., 1991; Wil-
iamson, 1992; Williamson et al., 1991) prior to detection
f neutralizing antiviral Ab (Parra et al., 1999; Stohlman et
al., 1986, 1999) suggests a possible Ab-independent role
during JHMV pathogenesis.
The observation that splenic B cells from naı¨ve mice
interact in vitro with cells infected with the A59 strain of
HV (MHV-A59), resulting in lysis of both the virus-
nfected cell and the B cell (Holmes et al., 1986; Nishioka
nd Welsh, 1993; Welsh et al., 1986; Wysocka et al., 1989),
uggests a potential for B cells in suppressing viral
eplication. Lysis is inhibited by polyclonal neutralizing
b (Coutelier et al., 1994), suggesting a role of the viral S
rotein, which is the sole viral target of neutralizing JHMV
b (Collins et al., 1982; Fleming et al., 1983b). Further-
ore, analysis of the cellular distribution of the MHV
eceptor (MHV-R), the ligand for the viral S protein, dem-
nstrated that B cells, and to a far lesser extent macro-
hages, but not T cells, express MHV-R (Coutelier et al.,
994). MHV-R is a murine membrane glycoprotein of the
iliary glycoprotein group within the immunoglobulin su-
erfamily, designated CEACAM1 (Beauchemin et al.,
999). These data suggest that interactions between the
protein, expressed on the surface of infected cells, and
he MHV-R expressed by B cells results in cytolysis.
ollowing interaction of the S protein and MHV-R the
ytoplasmic contents of the two cell types are mixed and
he MHV-A59-infected cells undergo apoptosis and lysis
Wysocka et al., 1989; Nishioka and Welsh, 1993). In
ddition, cytolysis is independent of interleukin (IL)-1,
umor necrosis factor (TNF)-b, Fas/FasL interactions, or
TNF-a (Nishioka and Welsh, 1993). Consistent with these
observations neither Fas/FasL interactions nor TNF ap-
pears to contribute to either JHMV clearance or patho-genesis (Parra et al., 2000; Stohlman et al., 1995). To-
gether these data suggested that cytolysis is mediated
via a fusion-dependent process.
Due to the rapid accumulation of B cells in the CNS of
infected mice (Dorries et al., 1991; Williamson, 1992;
Williamson et al., 1991) prior to the detection of neutral-
izing Ab (Parra et al., 1997, 1999; Stohlman et al., 1986,
1999), these studies were initiated to determine if JHMV-
infected cells were susceptible to B-cell-mediated lysis.
The data demonstrate that cytolysis occurs following
interaction with cells expressing the JHMV S protein, that
the interaction(s) leading to lysis is independent of other
viral proteins or MHV-induced effects on the host cell,
and that cytolysis occurs via a perforin-independent pro-
cess dependent upon cell–cell fusion. These results sug-
gest the potential for S protein–MHV-R interactions to
contribute to either JHMV clearance from the CNS or
prevention of JHMV reactivation.
RESULTS
MHV-R expression and B-cell-mediated cytolysis
Expression of MHV-R on B cells derived from the
spleens of naı¨ve C57BL/6 (H-2b), BALB/c (H-2d), and SJL
(H-2s) mice was examined by flow cytometry using anti-
CD19 to detect B cells and mAb CC-1 to detect MHV-R
expression. In C57BL/6 mice approximately 70% of cells
analyzed were CD191 and of this population .92% ex-
pressed MHV-R (Fig. 1). Analysis of cells from BALB/c
mice showed approximately 62% CD191 cells of which
.92% expressed MHV-R (Fig. 1). In contrast to B cells
derived from C57BL/6 and BALB/c mice, which express
MHV-R (Dveksler et al., 1993; Yokomori and Lai, 1992),
,1% of the CD191 cells derived from SJL mice expressed
MHV-R detected by mAb CC-1 (Fig. 1). SJL mice are
relatively resistant to JHMV infection (Stohlman and
Frelinger, 1978) and express only the CEACAM1b iso-
forms of the MHV-R in contrast to the CEACAM1a iso-
forms expressed by the susceptible C57BL/6 and BALB/c
mouse strains (Dveksler et al., 1993; Yokomori and Lai,
1992).
To determine if cells infected with JHMV were suscep-
tible to B-cell-mediated lysis, spleen cells were prepared
from naı¨ve C57BL/6, BALB/c, and SJL mice and com-
pared for their ability to lyse J774.1 (H-2d) cells infected
ith either JHMV or MHV-A59. Consistent with the ex-
ression of MHV-R, cells derived from both C57BL/6 and
ALB/c mice lysed cells infected with either JHMV or
HV-A59, but not uninfected cells (Fig. 2). Therefore,
ytolysis is independent of differences in the S proteins
f these two viruses. The MHV-A59 S protein contains a
42-amino-acid deletion relative to the S protein of JHMV
lthough there is 90% amino acid homology over the
emainder of the protein (Parker et al., 1989). No differ-
ence in lysis was observed comparing adherent-cell-
depleted spleen cells from naı¨ve BALB/c mice to a
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162 MORALES ET AL.splenic population containing .90% CD191 cells de-
pleted of T cells and CD11b1 cells by negative selection
sing Ab-coated magnetic beads (data not shown). Ad-
ition of 1 mg/ml anti-MHV-R mAb CC-1 inhibited lysis of
JHMV-infected cells (data not shown), similar to previous
results with MHV-A59-infected cells (Coutelier et al.,
1994), confirming a requirement for MHV-R–S protein
interactions. No lysis was detected with cells coated
with a peptide encompassing the immunodominant Ld-
estricted CD81 T cell epitope (Bergmann et al., 1993),
onfirming the naı¨ve status of the donor BALB/c mice
data not shown). Finally, similar results were obtained
ith spleen cells derived from either naı¨ve C57BL/6 or
ALB/c mice and IC-21 (H-2b) cells infected with either
JHMV or MHV-A59 (data not shown). These data demon-
strate that B cells from naı¨ve mice expressing the MHV-R
are able to lyse cells infected with JHMV via a major
histocompatibility complex-independent mechanism.
S protein expression is sufficient for cytolysis
To determine if cytolysis requires only an interaction
between the S protein and the MHV-R, or whether an-
FIG. 1. MHV-R expression on CD191 splenic B cells derived from
analyzed by flow cytometry for CD19 expression using a FITC-conjugate
PE-conjugated streptavidin.
FIG. 2. JHMV-infected cells are susceptible to B-cell-mediated lysis.
escribed under Materials and Methods. J774.1 cells were infected with JHMV o
ffector to target (E:T) ratios were tested for cytolysis using a 4-h 51Cr releasother MHV-encoded viral component expressed during
infection is required, lysis of cells infected with recom-
binant vaccinia virus (rVV) expressing either the JHMV S
protein or the MHV-A59 S protein were compared to
JHMV-infected cells. Cells expressing only the S proteins
encoded by JHMV or MHV-A59 were lysed at levels
comparable to those of JHMV infected cells (Fig. 3). No
cytolysis was detected using cells infected with a rVV
expressing b-galactosidase. These data demonstrate
that expression of the MHV S protein alone is sufficient
to initiate cytolysis and that no other MHV-encoded pro-
tein or viral-induced alteration in the host cells is re-
quired for B-cell-mediated cytolysis.
S protein fusion-dependent B cell cytolysis
B cells were tested for the ability to lyse cells infected
with the nonfusogenic MHV-2 strain (Tsai et al., 1999),
which utilizes the identical MHV-R (Chen et al., 1997), to
confirm a requirement for S-protein-mediated cell–cell
fusion (Wysocka et al., 1989). In contrast to cells infected
with either fusogenic JHMV or MHV-A59, cells infected
with MHV-2 were resistant to B-cell-mediated lysis (Fig.
/6, BALB/c, and SJL mice. Adherent-cell-depleted spleen cells were
. MHV-R expression was detected using a biotinylated mAb (CC-1) and
effectors were prepared from naı¨ve C57BL/6, BALB/c, or SJL mice asC57BLSpleen
r MHV-A59 for 6 h prior to assay at a m.o.i. of 5. Spleen cells at various
e assay. Data shown are representative of four experiments.
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163B CELL LYSIS OF MHV-INFECTED CELLS4A). To confirm both the requirement for S protein ex-
pression and cell–cell fusion, cytolysis of cells infected
with the fusogenic JHMV was carried out in the presence
of anti-S-protein mAb. MAb J.2.6 neutralizes JHMV and
inhibits S-protein-mediated fusion, while mAb J.7.5 exhib-
its neutralizing activity but does not inhibit fusion (Flem-
ing et al., 1983b). Both mAb inhibited B-cell-mediated
cytolysis (Fig. 4B), consistent with a requirement for S
protein–MHV-R interaction. B-cell-induced lysis of JHMV-
infected cells was also inhibited by anti-S-protein mAb
J.2.5 (Fig. 4B), which prevents cell–cell fusion but lacks
neutralizing activity (Fleming et al., 1983b). By contrast
mAb J.3.3, specific for the JHMV N protein (Fleming et al.,
1983b), which recognizes an epitope expressed on the
surface of infected cells (Kyuwa et al., 1994), did not
FIG. 3. MHV S protein expression is sufficient for cytolysis. J774.1
cells were infected with rVV expressing the S proteins derived from the
JHMV (vJS) and MHV-A59 (vAS) or a control rVV (vSC8) for 6 h at an
m.o.i. of 5 prior to labeling. Control cells were infected with JHMV 6 h
prior to labeling. Splenic effector cells were derived from naı¨ve BALB/c
mice. Specific 51Cr release was determined after 4 h incubation at
37°C. Data shown are representative of three experiments.
FIG. 4. Cytolysis requires cell–cell fusion. (A) J774.1 cells were infecte
stains of MHV at an m.o.i. of 5 and tested for susceptibility to B-cell-med
with the virus-infected cells at various ratios. (B) Spleen cells from BALB
JHMV-specific mAb [J.2.6 anti-S-protein mAb with both neutralization an
activity only (1/2), J.2.5 anti-S-protein mAb with fusion inhibition acti
initiation of the assay at final concentrations of 30–50 mg/ml. (C) B cells
774.1 cells were infected with JHMV at an m.o.i. of 5 mixed with effectors der
The percentage 51Cr release was determined after 4 h incubation at 37°C. Dnhibit cytolysis (Fig. 4B) nor did two additional isotype
ontrol mAb specific for irrelevant proteins (data not
hown). These data suggest that cytolysis requires both
protein–MHV-R interactions and the induction of cell–
ell fusion (Wysocka et al., 1989). Finally, spleen cells
derived from P2/2 mice lysed both JHMV- and MHV-A59-
infected cells (Fig. 4C), consistent with a mechanism
dependent on cell–cell fusion and independent of per-
forin and other potential cytolytic pathways, i.e., Fas/FasL
interactions, TNF-a, TNF-b, and IL-1 (Nishioka and
elsh, 1993).
HV-R expression is sufficient for cytolysis
To determine if lysis mediated by interactions of the
HV S protein and MHV-R expressed by B cells is
ependent upon a unique property of B cells, HeLa–
HVR, HeLa cells transfected with the gene encoding
HV-R (Gallagher, 1996), were examined for lysis of
HMV-infected cells. Expression of MHV-R on HeLa–
HVR cells was compared to the expression on CD191
B cells by flow cytometry. Although HeLa–MHVR cells
showed a bimodal distribution of MHV-R expression, the
average mean fluorescence intensity of MHV-R expres-
sion is similar to, or exceeds, the expression on cytolytic
CD191 B cells derived from BALB/c and C57BL/6 mice
(Fig. 5A). Due to the large size of HeLa cells compared to
splenic B cells, HeLa–MHVR and control HeLa–tTA cells
were added to the cytolytic assays at 20% the number of
added nonadherent spleen cells. Even though added at
reduced effector numbers, lysis of JHMV-infected cells
occurred following the addition of HeLa cells expressing
MHV-R, but not control HeLa cells (HeLa–tTA) (Fig. 5B).
Inhibiting S protein and MHV-R interactions via anti-
MHV-R mAb (1 mg/ml) completely abolished cytolysis
the nonfusogenic MHV-2 strain and the fusogenic JHMV and MHV-A59
sis at 6 h p.i. Effectors from the spleens of BALB/c mice were incubated
were tested for lysis of JHMV-infected cells in the presence of various
n inhibition (1/1) activities, J.7.5 anti-S-protein mAb with neutralization
ly (2/1), and J.3.3 anti-N-protein mAb]. The mAb were added at the
/2 mice were examined for their ability to lyse cells infected with JHMV.
2/2d with
iated ly
/c mice
d fusio
vity on
from P2ived from the spleens of BALB/c and P mice at indicated E:T ratios.
ata shown are representative of three or four experiments.
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164 MORALES ET AL.mediated by HeLa–MHVR cells (data not shown). These
data demonstrate that cytolysis resulting from interac-
tions between the S protein and the cells expressing
high levels of the MHV-R is not a unique property re-
stricted to B cells.
DISCUSSION
To begin to explore a potential Ab-independent role for
B cells in the pathogenesis of CNS infection, JHMV-
infected cells were examined for susceptibility to B-cell-
mediated lysis, similar to cells infected with MHV-A59
(Holmes et al., 1986). The data demonstrate that cells
infected with JHMV are susceptible to lysis. These data
show that expression of only the viral-encoded S protein
is required. Therefore, no other MHV-encoded protein or
alteration in host cell metabolism (Kyuwa et al., 1994)
participates in B-cell-mediated cytolysis. Lysis is pre-
vented by both neutralizing anti-JHMV S protein mAb and
mAb CC-1 specific for the isoforms of the CEACAM1a
allele of the MHV-R which blocks MHV infection in vitro
and in vivo (Dveksler et al., 1993; Coutelier et al., 1994;
FIG. 5. B cells are not required for cytolysis. (A) Surface MHV-R
expression on HeLa–MHVR cells compared to CD191 B cells derived
rom BALB/c and C57BL/6 mice. MHV-R expression was determined by
low cytometry using biotinylated anti-MHV-R CC-1 mAb and PE-con-
ugated streptavidin. Mean fluorescence intensity for each population
s shown in parentheses. (B) Lysis of JHMV-infected cells mediated by
eLa–MHVR cells compared to BALB/c-derived splenic B cells. J774.1
ells were infected with JHMV at an m.o.i. of 5. Nonadherent spleen
ells were added at various E:T ratios starting at 50:1. HeLa–MHVR and
ontrol HeLa–tTA were added at E:T ratios starting at 10:1. Specific 51Cr
elease was determined after 4 h incubation at 37°C. Data are repre-
entative of three experiments.mith et al., 1991). By contrast, neither mAb specific for
ther viral proteins nor isotype-matched mAb with otherpecificities inhibited lysis. The absence of a role for
as/FasL interactions, TNF-a, TNF-b, or IL-1 (Nishioka
nd Welsh, 1993) in lysis; the ability of B cells derived
rom P2/2 mice to lyse JHMV-infected cells; and the
nhibition of lysis by an anti-S-protein mAb which inhibits
usion, but does not neutralize, are all consistent with a
usion-dependent process (Wysocka et al., 1989). How-
ever, the mechanisms leading to a loss of membrane
permeability and induction of apoptosis (Nishioka and
Welsh, 1993) following interaction between the S protein
and the MHV-R are not clear.
The majority of B cells express MHV-R and are there-
fore capable of mediating the lysis and/or apoptosis of
JHMV-infected cells expressing the S protein on their
surface. B2201, surface Ig1 (Williamson, 1992; William-
son et al., 1991), and CD191 (Marten et al., 2001) B cells
re rapidly recruited into the CNS following JHMV infec-
ion. These data suggest that B-cell-mediated lysis
nd/or apoptosis may occur within the CNS. However,
he clearance of infectious JHMV from the CNS during
cute infection of mMT mice, which lack B cells and
therefore are unable to secrete Ab, is similar to that of wt
mice (Lin et al., 1999). These data suggest that B cells
and/or Ab provide a minor contribution to immune-medi-
ated viral clearance during acute infection. Although
these data are not consistent with an Ab-independent
B-cell-mediated mechanism, mMT mice are unable to
completely eliminate infectious virus from the CNS (Lin
et al., 1999) under conditions under which CD81 T cell
erforin-mediated cytolysis is down regulated (Berg-
ann et al., 1999). In addition, JHMV reactivates within
he CNS of mMT mice following the initial T-cell-mediated
reduction in infectious virus (Lin et al., 1999). The ability
of passively transferred polyclonal Ab containing neutral-
izing activity to suppress reactivation is consistent with a
role of anti-JHMV Ab in maintaining viral persistence (Lin
et al., 1999). Nevertheless, B cells may contribute to
clearance of infectious virus during acute infection, re-
sulting in suppression of virus reactivation, or play an
active role in preventing virus reactivation prior to the
induction of anti-S-protein Ab. The potential ability of B
cells to contribute to the complete suppression of infec-
tious virus and/or prevention of viral recrudescence may
be masked via passive Ab transfer (Lin et al., 1999).
In wt mice induction of anti-S-protein Ab with either
neutralizing or fusion-inhibiting activities, or accumula-
tion of B cells in the CNS secreting Ab with these func-
tions, would inhibit a potential Ab-independent B-cell-
dependent mechanism of viral suppression. This sug-
gests that during infection, an Ab-independent
mechanism could contribute to viral clearance only early,
i.e., during the loss of perforin-mediated cytolysis by
CNS-infiltrating virus-specific CD81 T cells (Bergmann et
al., 1999) but prior to the induction of anti-S-protein Ab
with neutralizing or fusion-inhibiting activities. Consis-
tent with this hypothesis, virus is cleared from the CNS of
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165B CELL LYSIS OF MHV-INFECTED CELLSP2/2 mice (Lin et al., 1997). MHV-R1 B cells that are
rapidly recruited into the CNS during acute infection
(Dorries et al., 1991; Williamson, 1992; Williamson et al.,
1991) are presumably not virus specific based on the
absence of detectable serum neutralizing antiviral Ab
(Parra et al., 1997, 1999; Stohlman et al., 1986, 1999).
However, it is not clear how rapidly B cells secreting
virus-specific anti-S-protein Ab are induced in the periph-
ery or how rapidly they infiltrate the CNS following JHMV
infection. These data suggest that MHV-R1 B cells may
ndeed contribute to JHMV clearance in an Ab-indepen-
ent manner. B cells may also sequester virus following
protein–MHV-R interactions, thus effectively limiting
irus spread in addition to an Ab-independent mecha-
ism of virus suppression. Finally, B cell–S protein inter-
ctions lead to the lysis of both the B cell and the
irus-infected cell (Wysocka et al., 1989), suggesting that
his interaction may contribute to the observations that
erum neutralizing Ab are not detectable until the major-
ty of infectious virus, and presumably infected cells
xpressing the S protein, has been eliminated (Lin et al.,
997; Parra et al., 1997, 1999; Stohlman et al., 1986).
These data demonstrate that MHV-R1 B cells from
usceptible mice lyse JHMV-infected cells via a fusion-
ependent mechanism. The rapid recruitment of MHV-R1
B cells into the infected CNS may constitute an innate
immune response contributing to the reduction of infec-
tious CNS virus and prevent virus reactivation, either via
a lytic interaction or via the sequestration of infectious
virus. An interaction between MHV-R1 B cells and JHMV-
nfected cells also provides a plausible mechanism to
xplain the delayed appearance of JHMV-neutralizing Ab
ntil after the majority of infectious virus has been
leared from the CNS by a vigorous cell-mediated im-
une response.
MATERIALS AND METHODS
ice
BALB/c, C57BL/6, and perforin-deficient (P2/2) mice on
the C57BL/6 genetic background (C57BL/6-PfptmlSdz) were
purchased from The Jackson Laboratory (Bar Harbor,
ME). SJL mice were purchased from the National Insti-
tutes of Health (Frederick, MD). Mice were purchased at
6 weeks of age and all mice were used between 7 and
14 weeks of age. P2/2 mice were maintained locally in a
sterile environment by intercrossing. No age- or gender-
dependent differences were noted.
Viruses
Plaque-purified populations of the MHV strains JHMV,
MHV-A59, and MHV-2 were propagated and plaque as-
sayed on DBT cell monolayers as described previously
(Bergmann et al., 1993). rVV expressing the S protein
derived from JHMV, the S protein derived from MHV-A59,and Escherichia coli b-galactosidase were propagated
in HeLa cells and plaque assayed on monolayers of
BSC-1 cells as previously described (Stohlman et al.,
1993).
Effector cell preparation and cell lines
Single-cell suspensions from spleens of naı¨ve mice
were prepared in RPMI medium. Following red blood cell
lysis using Gey’s solution, the cells were suspended in
RPMI medium containing 2% fetal calf serum (FCS) and
incubated on plastic petri plates at 37°C for 1 h to
remove adherent cells. The resulting nonadherent pop-
ulations contained 50 to 60% CD191 B cells as deter-
ined by flow cytometry (see below). These macro-
hage-depleted populations were used in most experi-
ents as cytolytic effectors. HeLa cells expressing the
HV-R, designated HeLa–MHVR, and a control line, des-
gnated HeLa–tTA (Gallagher, 1996), were kindly pro-
ided by Dr. Thomas Gallagher (Loyola University Med-
cal Center, Chicago, IL). HeLa cells were grown in Dul-
ecco’s modified MEM (DMEM) containing 10% FCS.
low cytometry
Splenocyte samples were blocked at 4°C for 15 min
ith anti-CD16/CD32 (mAb 2.4G2; PharMingen, San Di-
go, CA) and a mixture of equal amounts of goat serum,
uman serum, and horse serum was added to a final
oncentration of 10% prior to staining. Cells were
ashed with PBS containing 0.1% bovine serum albumin
rior to staining of B cells with fluorescein isothiocya-
ate-conjugated anti-CD19 (mAb ID3; PharMingen) at
°C for 15 to 20 min. MHV-R expression was examined
y incubation with biotinylated mAb CC-1, which detects
EACAM1a but not CEACAM1b (Williams et al., 1990),
nd visualized with phycoerythrin-conjugated streptavi-
in (PharMingen). Samples were analyzed on a FACStar
low cytometer (Becton–Dickinson, Mountain View, CA).
arget cells
The J774.1 (H-2d) and IC-21 (H-2b) cell lines were prop-
agated in DMEM containing 10% FCS. Cells were plated
at a concentration of 1 3 106 in 100-mm plates for 8 h
prior to infection with MHV at a m.o.i. of 1 to 5. MHV-
infected cells were incubated for 6 h at 37°C prior to use.
J774.1 cells were infected with rVV at an m.o.i. of 5 to 10
and were incubated for 10 h at 37°C prior to use.
Cytotoxic assays
Infected and uninfected cells (1 3 106) were labeled at
37°C for 1 h with 60 mCi of Na51CrO4 (NEN Life Sciences,
Boston, MA) and washed three times prior to use. La-
beled cells in 96-well microtiter plates (1 3 104/well)
were mixed with varying numbers of effector cells to
achieve the desired effector/target ratios. Some cytolytic
p
a
a
c
r
B
B
B
C
C
C
K
L
L
L
M
N
N
P
P
P
P
P
S
166 MORALES ET AL.assays were performed in the presence of anti-JHMV-
specific mAb J.2.5, J.2.6, J.7.5 (anti-S-protein), and J.3.3
(anti-nucleocapsid protein) (Fleming et al., 1983b), pre-
ared either as serum-free culture supernatants or as
scities, or anti-MHV-R mAb (CC-1). After 4 h incubation
t 37°C, 0.1 ml was removed and counted in a gamma
ounter. Data are presented as percentage specific 51Cr
elease 5 100 3 (experimental cpm 2 spontaneous
cpm)/(maximum release cpm 2 spontaneous cpm).
Spontaneous release in all assays was #20% of total.
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